Drugs / mRNA-1010.3
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT05827068 Comparator | Mar → Nov 2023 | influenza | ModernaTX, Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mRNA-1010.3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05827068 ↗ |